Breast Cancer Special Issue 2019

Want to support someone during cancer treatment? Offer your ear, not your opinion.

Survivors at risk of lymphedema are asked to follow a standard list of lifestyle adaptations, but two experts say those guidelines may change.

Before undergoing genetic testing, stop to consider its effect on your daily experience, including your ability to get life insurance.

Most who undergo mastectomy lose feeling in their chests, but microsurgeons can now restore sensation by connecting nerves during tissue-based reconstruction.

Linking a targeted drug to a chemotherapy shows promise for treating metastatic triple-negative breast cancer.

In a gel applied directly to the breasts, the anti-estrogen drug tamoxifen may help prevent cancer and fight DCIS — with few side effects.

New treatments are lengthening life and improving its quality for some with metastatic breast cancer.

Two decades ago, a patient with HER2-positive breast cancer had a single targeted drug option. Now a plethora of new and emerging treatments fill the landscape.

Liquid biopsies may reveal who needs treatment for recurrent breast cancer — and, just as important, who doesn’t.

We hope this issue helps answer your questions about treatments and side effects, leaving you better informed and more confident as you make decisions about your care.

The development of the drug Herceptin (trastuzumab) to treat HER2-positive breast cancer marked an enormous milestone: In the opinion of many, it represented the birth of targeted therapy for cancer.